breast cancer
dense breast tissue
dense breasts
mammography
Low dose Molecular Breast Imaging
improved cancer detection
dose vs cancer detection balance
better cancer detection rate
women
high radiation dose
large numbers of cancers
screening technology
MBI market
feasibility study
market needs
regulatory viability of Kromekâ€™s technology
number of innovative platform technologies
higher sensitivity
specificity
mammogram distinguishing tumours
fewer false alarms
system
inability
application
Europe
current offering
non-cancerous features
Euros
USA
difficulty
optimised diagnosis pathways
detectors
Phase
years
barriers
adoption
sales
use
Work
biopsy
commercialisation